TNFAIP3 and atherosclerosis: However, the lack of data about the expression of GPR39 and A20 in the macrophage of patients with atherosclerosis (especially in high ox-LDL patients) is a limitation of the present study, which will be investigated in the next experiments to further support the conclusions in this study.